Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 4, 2019Scandinavian Journal of GastroenterologyOpen Access

Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

TTTenglong TangCentral South UniversityHAHamzah Abu‐SbeihThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteWLWenyi LuoYale University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tang et al. (2019) studied this question.

synapsesocial.com/papers/69e90f73f101b906ae2437bfhttps://doi.org/10.1080/00365521.2019.1594356
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study2018 · 215 citations
  2. 2Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson2018 · 247 citations
  3. 3Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group2017 · 2,021 citations
  4. 4Managing Adverse Events With Immune Checkpoint Agents2016 · 48 citations
  5. 5Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity?2018 · 78 citations